# OXN PR Compared to OXY PR in Subjects With Postoperative Pain After Knee Arthroplasty

> **NCT01083485** · PHASE4 · COMPLETED · sponsor: **Mundipharma Oy** · enrollment: 137 (actual)

## Conditions studied

- Post Operative Pain

## Interventions

- **DRUG:** Oxycodone/Naloxone PR 20/10mg or 10/5mg tablets
- **DRUG:** Oxycodone

## Key facts

- **NCT ID:** NCT01083485
- **Lead sponsor:** Mundipharma Oy
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2010-10
- **Final completion:** 2010-11
- **Target enrollment:** 137 (ACTUAL)
- **Last updated:** 2012-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01083485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01083485, "OXN PR Compared to OXY PR in Subjects With Postoperative Pain After Knee Arthroplasty". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01083485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*